{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:18:22Z","timestamp":1784823502604,"version":"3.55.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft DFG","award":["SFB643, SPP1468, FOR661"],"award-info":[{"award-number":["SFB643, SPP1468, FOR661"]}]},{"name":"Bundesministerium f\u00fcr Forschung und Bildung BMBF","award":["project ANKYLOSS"],"award-info":[{"award-number":["project ANKYLOSS"]}]},{"name":"European Union projects Masterswitch, Kinacept and Adipoa, the Interdisziplin\u00e4res Zentrum f\u00fcr Klinische Forschung Erlangen and the Spondyloarthritis Immunology Reserach Alliance","award":["SpIRAL"],"award-info":[{"award-number":["SpIRAL"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.berh.2010.01.005","type":"journal-article","created":{"date-parts":[[2010,5,31]],"date-time":"2010-05-31T06:21:44Z","timestamp":1275286904000},"page":"363-371","source":"Crossref","is-referenced-by-count":66,"title":["Can we stop progression of ankylosing spondylitis?"],"prefix":"10.1016","volume":"24","author":[{"given":"Georg","family":"Schett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Rudwaleit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 3","key":"10.1016\/j.berh.2010.01.005_bib1","doi-asserted-by":"crossref","first-page":"iii8","DOI":"10.1136\/ard.61.suppl_3.iii8","article-title":"Ankylosing spondylitis: an overview","volume":"61","author":"Sieper","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2010.01.005_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/path.1700710111","article-title":"Lesions of cartilaginous joints in ankylosing spondylitis","volume":"71","author":"Cruickshank","year":"1956","journal-title":"The Journal of Pathology and Bacteriology"},{"issue":"31","key":"10.1016\/j.berh.2010.01.005_bib3","doi-asserted-by":"crossref","first-page":"28659","DOI":"10.1074\/jbc.M300671200","article-title":"Prostaglandin E2 stimulates bone sialoprotein (BSP) expression through cAMP and fibroblast growth factor 2 response elements in the proximal promoter of the rat BSP gene","volume":"278","author":"Samoto","year":"2003","journal-title":"The Journal of Biological Chemistry."},{"issue":"11","key":"10.1016\/j.berh.2010.01.005_bib4","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1172\/JCI0215681","article-title":"Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair","volume":"109","author":"Zhang","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2010.01.005_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1196\/annals.1346.005","article-title":"BMP and BMP inhibitors in bone","volume":"1068","author":"Rosen","year":"2006","journal-title":"Annals of the New York Academy of Sciences"},{"key":"10.1016\/j.berh.2010.01.005_bib6","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.21897","article-title":"Noggin haploinsufficiency differentially affects tissue responses in destructive and remodeling arthritis","volume":"54","author":"Lories","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.005_bib7","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Minireview: targeting the Wnt\/\u00df-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"issue":"280","key":"10.1016\/j.berh.2010.01.005_bib8","doi-asserted-by":"crossref","first-page":"26770","DOI":"10.1074\/jbc.M504308200","article-title":"SOST is a ligand for LRP5\/LRP6 and a Wnt signaling inhibitor","volume":"22","author":"Sem\u00ebnov","year":"2005","journal-title":"The Journal of Biological Chemistry."},{"key":"10.1016\/j.berh.2010.01.005_bib9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/nm1538","article-title":"Dickkopf-1 is a master regulator of joint remodeling","volume":"13","author":"Diarra","year":"2007","journal-title":"Nature Medicine"},{"key":"10.1016\/j.berh.2010.01.005_bib10","article-title":"Blockade of Dickkopf-1 induces fusion of sacroiliac joints","author":"Uderhardt","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"11","key":"10.1016\/j.berh.2010.01.005_bib11","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1002\/art.24888","article-title":"Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis","volume":"60","author":"Appel","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"6053","key":"10.1016\/j.berh.2010.01.005_bib12","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/319516a0","article-title":"Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors","volume":"319","author":"Bertolini","year":"1986","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.berh.2010.01.005_bib13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1359\/jbmr.090305","article-title":"Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts","volume":"24","author":"Vincent","year":"2009","journal-title":"Journal of Bone and Mineral Research."},{"key":"10.1016\/j.berh.2010.01.005_bib14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1136\/bmj.300.6724.563","article-title":"Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis","volume":"300","author":"Ralston","year":"1990","journal-title":"BMJ"},{"key":"10.1016\/j.berh.2010.01.005_bib15","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1002\/art.22060","article-title":"Immunohistologic analysis of zygapophyseal joints in patients with ankylosing spondylitis","volume":"54","author":"Appel","year":"2006","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2010.01.005_bib16","article-title":"Evidence for a distinctive pattern of bone formation in enthesophytes","author":"Benjamin","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1016\/j.berh.2010.01.005_bib17","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/ard.2005.041137","article-title":"European league against rheumatism. ASAS\/EULAR recommendations for the management of ankylosing spondylitis","volume":"65","author":"Zochling","year":"2006","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.berh.2010.01.005_bib18","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis disease activity index","volume":"21","author":"Garrett","year":"1994","journal-title":"The Journal of Rheumatology"},{"issue":"1","key":"10.1016\/j.berh.2010.01.005_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.berh.2010.01.005_bib20","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"van der Heijde","year":"2009","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"8","key":"10.1016\/j.berh.2010.01.005_bib21","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","article-title":"Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis","volume":"44","author":"Anderson","year":"2001","journal-title":"Arthritis and Rheumatism"},{"issue":"11","key":"10.1016\/j.berh.2010.01.005_bib22","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1136\/ard.2003.016717","article-title":"Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis","volume":"63","author":"Brandt","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"3","key":"10.1016\/j.berh.2010.01.005_bib23","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/art.23260","article-title":"Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes","volume":"58","author":"Sieper","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"8","key":"10.1016\/j.berh.2010.01.005_bib24","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1002\/art.20446","article-title":"What is the most appropriate radiologic scoring method for ankylosing spondylitis? A comparison of the available methods based on the outcome measures in rheumatology clinical trials filter","volume":"50","author":"Wanders","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2010.01.005_bib25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2004.029298","article-title":"Inflammation in ankylosing spondylitis: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging","volume":"64","author":"Baraliakos","year":"2005","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1016\/j.berh.2010.01.005_bib26","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/art.24425","article-title":"Development of a radiographic scoring tool for ankylosing spondylitis only based on bone formation: addition of the thoracic spine improves sensitivity to change","volume":"61","author":"Baraliakos","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2010.01.005_bib27","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/ard.2003.011247","article-title":"How to diagnose axial spondyloarthritis early","volume":"63","author":"Rudwaleit","year":"2004","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"12","key":"10.1016\/j.berh.2010.01.005_bib28","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1093\/rheumatology\/kei046","article-title":"Persistent reduction of spinal inflammation as assessed by magnetic resonance imaging in patients with ankylosing spondylitis after 2 yrs of treatment with the anti-tumour necrosis factor agent infliximab","volume":"44","author":"Sieper","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.berh.2010.01.005_bib29","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/art.21790","article-title":"Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab: results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study","volume":"54","author":"Braun","year":"2006","journal-title":"Arthritis and Rheumatism"},{"issue":"12","key":"10.1016\/j.berh.2010.01.005_bib30","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1002\/art.23044","article-title":"Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study","volume":"56","author":"Lambert","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2010.01.005_bib31","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/art.23471","article-title":"Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"10","key":"10.1016\/j.berh.2010.01.005_bib32","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/art.23901","article-title":"Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis","volume":"58","author":"van der Heijde","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"4","key":"10.1016\/j.berh.2010.01.005_bib33","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1186\/ar2794","article-title":"Canadian (M03-606) study group; ATLAS study group. Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years","volume":"11","author":"van der Heijde","year":"2009","journal-title":"Arthritis Research & Therapy"},{"issue":"2","key":"10.1016\/j.berh.2010.01.005_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/art.22372","article-title":"Evidence for uncoupling of inflammation and joint remodeling in a mouse model of spondylarthritis","volume":"56","author":"Lories","year":"2007","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1016\/j.berh.2010.01.005_bib35","doi-asserted-by":"crossref","first-page":"R104","DOI":"10.1186\/ar2496","article-title":"The relationship between inflammation and new bone formation in patients with ankylosing spondylitis","volume":"10","author":"Baraliakos","year":"2008","journal-title":"Arthritis Research & Therapy"},{"issue":"1","key":"10.1016\/j.berh.2010.01.005_bib36","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.24132","article-title":"Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation","volume":"60","author":"Maksymowych","year":"2009","journal-title":"Arthritis and Rheumatism"},{"issue":"Suppl. II","key":"10.1016\/j.berh.2010.01.005_bib37","first-page":"130","article-title":"MRI-inflammation of the vertebral unit (VU) only marginally contributes to new syndesmopyhte formation in that unit: a multi-level-analysis","volume":"67","author":"van der Heijde","year":"2008","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"11","key":"10.1016\/j.berh.2010.01.005_bib38","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/ncprheum0930","article-title":"Relevance of osteoproliferation as an outcome parameter in ankylosing spondylitis","volume":"4","author":"Appel","year":"2008","journal-title":"Nature Clinical Practice. Rheumatology"},{"key":"10.1016\/j.berh.2010.01.005_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/ard.2007.071159","article-title":"TNF blockers and structural remodeling in ankylosing spondylitis- what is reality and what is fiction?","volume":"66","author":"Schett","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"10.1016\/j.berh.2010.01.005_bib40","first-page":"60","article-title":"Retardation of ossification of the lumbar vertebral column in ankylosing spondylitis by means of phenylbutazone","volume":"5","author":"Boersma","year":"1976","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"6","key":"10.1016\/j.berh.2010.01.005_bib41","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1002\/art.21054","article-title":"Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial","volume":"52","author":"Wanders","year":"2005","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1016\/j.berh.2010.01.005_bib42","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1742-7843.2007.00149.x","article-title":"Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the bone healing process","volume":"102","author":"Vuolteenaho","year":"2008","journal-title":"Basic & Clinical pharmacology & Toxicology"},{"issue":"5","key":"10.1016\/j.berh.2010.01.005_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/rheumatology\/kep022","article-title":"Adalimumab is effective and well tolerated in treating patients with ankylosing spondylitis who have advanced spinal fusion","volume":"48","author":"Rudwaleit","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.berh.2010.01.005_bib44","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/rheumatology\/ken357","article-title":"What is the most important outcome parameter in ankylosing spondylitis?","volume":"47","author":"Braun","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"12","key":"10.1016\/j.berh.2010.01.005_bib45","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.2106\/00004623-200212000-00001","article-title":"Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients","volume":"84-A","author":"Govender","year":"2002","journal-title":"The Journal of Bone and Joint Surgery. American Volume"},{"issue":"4","key":"10.1016\/j.berh.2010.01.005_bib46","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1359\/jbmr.081206","article-title":"Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis","volume":"24","author":"Li","year":"2009","journal-title":"Journal of Bone and Mineral Research."},{"issue":"9","key":"10.1016\/j.berh.2010.01.005_bib47","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/art.24767","article-title":"Tumor necrosis factor alpha and RANKL blockade cannot halt bony spur formation in experimental inflammatory arthritis","volume":"60","author":"Schett","year":"2009","journal-title":"Arthritis and Rheumatism"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694210000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694210000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T04:35:05Z","timestamp":1711514105000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694210000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S1521694210000069"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2010.01.005","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}